Smoking and selected DNA repair gene polymorphisms in controls: Systematic review and meta-analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 12, 2010, Pages 3055-3086

  Hodgson, M Elizabeth ^a   Poole, Charles ^a   Olshan, Andrew F ^a,b   North, Kari E ^a,c   Zeng, Donglin ^a   Millikan, Robert C ^a,c  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; GLUTAMINE; HISTIDINE; LYSINE; METHIONINE; THREONINE; TRYPTOPHAN;

DNA REPAIR; ENVIRONMENTAL EXPOSURE; GENE; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTEMATIC REVIEW; XPD GENE; XRCC1 GENE; XRCC3 GENE;

DNA REPAIR; DNA REPAIR ENZYMES; ENVIRONMENTAL EXPOSURE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RESEARCH DESIGN; SMOKING;

EID: 78650366054     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0877     Document Type: Review

References (91)

1. Prentice RL, Vollmer WM, Kalbfleisch JD. On the use of case series to identify disease risk factors. Biometrics 1984;40:445-58.
2. Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 1994;13:153-62.
3. Yang Q, Khoury MJ, Flanders WD. Sample size requirements in caseonly designs to detect gene-environment interaction. Am J Epidemiol 1997;146:713-20.
4. Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology 1999;10:481-7. (Pubitemid 29398902)
5. Greenland S, Poole C. Invariants and noninvariants in the concept of interdependent effects. Scand J Work Environ Health 1988;14:125-9.
6. Rothman KJ. Modern Epidemiology, 3rd ed. Philadelphia: PA, Lippincott Williams & Wilkins; 2008.
7. Albert PS, Ratnasinghe D, Tangrea J, Wacholder S. Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol 2001;154:687-93. (Pubitemid 32971488)
8. Tan Q, Yashin AI, Bladbjerg EM, et al. A case-only approach for assessing gene by sex interaction in human longevity. J GerontolA Biol Sci MedSci 2002;57:B129-B33.
9. Weinberg CR, Umbach DM. Choosing a retrospective design to assess joint genetic and environmental contributions to risk. [see comments.]. [Review] [32 refs]. Am J Epidemiol 2000;152:197-203.
10. Liu X, Fallin MD, Kao WH. Genetic dissection methods: Designs used for tests of gene-environment interaction. Curr Opin Genet Dev 2004;14:241-5.
11. Manuguerra M, Saletta F, Karagas MR, et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: A HuGE review. Am J Epidemiol 2006;164:297-302. (Pubitemid 44297335)
12. Wu XF, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene 2004;23:6500-23.
13. Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis. Int J Med Sci 2007;4:59-71.
14. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis. Lung Cancer 2006;54:267-83.
15. Qu T, Morimoto K. X-ray repair cross-complementing group 1 polymorphisms and cancer risks in Asian populations: A mini review. Cancer Detect Prev 2005;29:215-20.
16. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29.
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
19. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. StatMed 1998;17:841-56.
20. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: A comparison of methods. StatMed 1999;18:2693-708.
21. Stern MC, Johnson LR, Bell DA, Taylor JA. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomark Prev 2002;11:1004-11.
22. Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomark Prev 2006; 15:2384-90.
23. Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario Site of the Breast Cancer Family Registry. Cancer Epidemiol Biomark Prev 2004;13:583-91.
24. Affatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammenheuser MM, Abdel-Rahman SZ. Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ Mole Mutagenesis 2004;44:65-73.
25. Wang Y, Liang D, Spitz MR, et al. XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer 2003;98:1701-6.
26. David-Beabes GL, London SJ. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 2001;34:333-9.
27. Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10:217-22.
28. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 2002;62:4630-6.
29. Huang WY, Chow WH, Rothman N, et al. Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 2005;26:1354-9.
30. Justenhoven C, Hamann U, Pesch B, et al. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomark Prev 2004;13:2059-64.
31. Kelsey KT, Park S, Nelson HH, Karagas MR. A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1337-41.
32. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC, Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 2006;66:2860-8.
33. Ryk C, Kumar R, Thirumaran RK, Hou SM. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer 2006;54:285-92.
34. Shen HB, Xu YC, Qian Y, et al. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 2000;88:601-6.
35. Shen J, Gammon MD, Terry MB, et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomark Prev 2005;14:336-42.
36. Smedby KE, Lindgren CM, Hjalgrim H, et al. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev 2006;15:258-65.
37. Terry MB, Gammon MD, Zhang FF, et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomark Prev 2004;13:2053-8.
38. Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 2001;22:593-7.
39. Garcia-Closas M, Malats N, Real FX, et al. Genetic variation in the nucleoticle excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomark Prev 2006;15:536-42.
40. Harms C, Salama SA, Sierra-Torres CH, Cajas-Salazar N, Au WW. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 2004;44:74-82.
41. Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002;23:599-603.
42. Hung RJ, Brennan P, Canzian F, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Nat Cancer Insti 2005;97:567-76.
43. Ito H, Matsuo K, Hamajima N, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 2004; 25:1395-401.
44. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett 2007;245:61-8.
45. Matullo G, Guarrera S, Sacerdote C, et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 2005;14:2569-78.
46. Metsola K, Kataja V, Sillanpaa P, et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res 2005;7:R987-R97.
47. Olshan AF, Watson MA, Weissler MC, Bell DA. XRCC1 polymorphisms and head and neck cancer. Cancer Lett 2002;178:181-6.
48. Park JY, Lee SY, Jeon HS, et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:23-7.
49. Ramachandran S, Ramadas K, Hariharan R, Kumar RR, Pillai MR. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncology 2006;42:350-62.
50. Schabath MB, Delclos GL, Grossman HB, et al. Polymorphisms in XPD Exons 10 and 23 and bladder cancer risk. Cancer Epidemiology Biomarkers & Prevention 2005;14:878-84.
51. Schneider J, Classen V, Bernges U, Philipp M. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. Int J Mol Med 2005;16:709-16.
52. Shen H, Sturgis EM, Dahlstrom KR, Zheng Y, Spitz MR, Wei Q. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 2002;99:869-72.
53. Shen M, Hung RJ, Brennan P, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 2003;12:1234-40.
54. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:125-31.
55. Stern MC, Umbach DM, Lunn RM, Taylor JA. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:939-43.
56. Xing D, Tan W, Wei Q, Lin D. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 2002;38:123-9.
57. Yu HP, Wang XL, Sun X, et al. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2004;154:10-5.
58. Yu HP, Zhang XY, Wang XL, et al. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev 2004;28:194-9.
59. Zhou W, Liu G, Miller DP, et al. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002;62:1377-81.
60. Zhou W, Liu G, Miller DP, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:359-65.
61. Han JL, Hankinson SE, De Vivo I, et al. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res 2003;63:8536-41.
62. Jin MJ, Chen K, Song L, et al. The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population. Cancer Genet Cytogenet 2005;163:38-43.
63. Misra RR, Ratnasinghe D, Tangrea JA, et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 2003;191:171-8.
64. Patel AV, Calle EE, Pavluck AL, Feigelson HS, Thun MJ, Rodriguez C. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res 2005;7:R1168-R73.
65. Cao Y, Miao XP, Huang MY, et al. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 2006; 6:167
66. Koyama A, Kubota Y, Shimamura T, Horiuchi S. Possible association of the X-ray cross complementing gene 1 (XRCC1) Arg280His polymorphism as a risk for rheumatoid arthritis. RheumatolInt 2006;26:749-51.
67. Kocabas NA, Karahalil B. XRCC1 Arg399Gln genetic polymorphism in a Turkish population. Int J Toxicol 2006;25:419-22.
68. Lei YC, Hwang SJ, Chang CC, et al. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. MutatRes 2002; 519:93-101.
69. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: Effects on aflatoxin B-1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61.
70. Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001;22:1437-45.
71. Skjelbred CF, Svendsen M, Haugan V, et al. Influence of DNA repair gene polymorphisms of hOGG1, XRCC1, XRCC3, ERCC2 and the folate metabolism gene MTHFR on chromosomal aberration frequencies. MutatRes 2006;602:151-62.
72. Tuimala J, Szekely G, Wikman H, et al. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations. MutatRes 2004;554:319-33.
73. Wilding CS, Relton CL, Rees GS, Tarone RE, Whitehouse CA, Tawn EJ. DNA repair gene polymorphisms in relation to chromosome aberration frequencies in retired radiation workers. MutatRes 2005;570:137-45.
74. Zijno A, Verdina A, Galati R, et al. Influence of DNA repair polymorphisms on biomarkers of genotoxic damage in peripheral lymphocytes of healthy subjects. MutatRes 2006;600:184-92.
75. Hoffmann H, Isner C, Hogel J, Speit G. Genetic polymorphisms and the effect of cigarette smoking in the comet assay. Mutagenesis 2005;20:359-64.
76. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls! Am J Epidemiol 1996;144:207-13.
77. Liu Y, Yoshimura K, Hanaoka T, et al. Association of habitual smoking and drinking with single nucleotide polymorphism (SNP) in 40 candidate genes: Data from random population-based Japanese samples. J Hum Genet 2005.
78. Naccarati A, Soucek P, Stetina R, et al. Genetic polymorphisms and possible gene-gene interactions in metabolic and DNA repair genes: Effects on DNA damage. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 2006;593:22-31.
79. Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004;25:757-63.
80. Vodicka P, Stetina R, Polakova V, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2007;28:657-64.
81. Tyndale RF. Genetics of alcohol and tobacco use in humans. Ann Med 2003;35:94-121.
82. Andrews AD, Barrett SF, Robbins JH. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. Proc Natl Acad Sci USA 1978;75:1984-8.
83. Inoshima I, Kuwano K, Hamada N, et al. Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2004;286:L727-L33.
84. Kurz EU, Lees-Miller SP. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 2004;3:889-900.
85. Reardon JT, Bessho T, Kung HC, Bolton PH, Sancar A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1997;94:9463-8.
86. Shackelford RE, Manuszak RP, Heard SC, Link CJ, Wang S. Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson's disease. Med Hypotheses 2005;64:736-41.
87. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: PA, Lippincott-Raven; 1998.
88. Morabia A, Stellman SD, Wynder EL. Smoking prevalence in neighborhood and hospital controls: Implications for hospital-based case-control studies. J Clin Epidemiol 1996;49:885-9.
89. Ramos E, Lopes C, Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol 2004;14:437-41.
90. Holt VL, Martin DP, LoGerfo JP. Correlates and effect of non-response in a postpartum survey of obstetrical care quality. J Clin Epidemiol 1997;50:1117-22.
91. Heilbrun LK, Nomura A, Stemmermann GN. The effects of nonresponse in a prospective study of cancer. Am J Epidemiol 1982;116:353-63.